First Ever Moon Advertisement for Male Genital Odor Removal Cream NodorO, to Appear live on May 9th 2009 @ 10 PM. EST First ever moon advertisement for male genital odor removal cream NodorO, to appear live on May 9th, 2009 @ 10 PM. EST during the next full moon. (PRWeb Apr 25, 2009)
Read the full story at http://www.prweb.com/releases/2009/04/prweb2359374.htm
Source: www.prweb.comAtlanta School of Massage and Atlanta Institute of Aesthetics Announce Partnership with Salonpost.com Job seekers looking for Atlanta spa careers can post their resume as well as search for jobs and continuing education opportunities. (PRWeb Apr 26, 2009)
Read the full story at http://www.prweb.com/releases/2009/04/prweb2345464.htm
Source: www.prweb.comFor Erectile Dysfunction, Physicians Indicate That Opportunity Exists For Emerging Therapies With Improved Efficacy Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although surveyed primary care physicians (PCPs) are generally satisfied with the efficacy of available phosphodiesterase type 5 (PDE5) inhibitors such as Pfizer's Viagra, Eli Lilly's Cialis and Bayer Healthcare/Schering-Plough/GlaxoSmithKline's Levitra, they are less satisfied with the efficacy of this drug class in difficult-to-treat patient subpopulations.
Source: www.medicalnewstoday.comIn Treating Lower Urinary Tract Symptoms, Generics Less Effective/Safe Than Branded Medications Men taking generic drugs may be more likely to have less effective results and more adverse events than if they were using branded medications, according to new data from researchers in New York.
Source: www.medicalnewstoday.comLabopharm Reports Results For Phase III Study On Twice-daily Tramadol-acetaminophen Formulation Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced the results of its recently completed North American Phase III clinical trial for its twice-daily formulation of tramadol and acetaminophen (study 06CCL3-001). Study 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm's twice-daily tramadol-acetaminophen formulation to placebo in the treatment of moderate to severe acute low back pain.
Source: www.medicalnewstoday.com
# posted by Network @ 3:35 PM
